Abstract Cardiovascular diseases (CVD) are one of the main causes of mortality in the world. Dyslipidemia treatment can reduce the number of deaths caused by CVD, by decreasing the lipid profile. Evaluate the pharmacotherapeutic follow-up effectiveness in patients with dyslipidemia, regarding clinical and laboratory aspects. A quasi-experimental trial was performed in 12 months. The studied population was included patients with dyslipidemia who received a pharmacotherapeutic follow-up, which was evaluated according to the Pharmacotherapy Workup developed by the Brazilian Ministry of Health. Clinical and laboratory evaluations were performed at the baseline, after a 6 and 12-months period. The statistical analyzes were performed with the normality test of Lilliefors, Cramer Von Misses, and Anderson Darling, later the t-paired test. This study demonstrated that after 6-months of intervention, statistically significant results were verified in the reduction of LDL-cholesterol, total cholesterol, increase in HDL-cholesterol, and reduction in the blood pressure. It was observed that for high-risk patients, the achievement of targets in the lipid profile and HbA1C occurred only after 12-months, because, this population needs more aggressive targets and expressive interventions. Pharmacotherapeutic follow-up in patients with dyslipidemia reduced lipid blood levels and promoted positive clinical and laboratory outcomes.

ABSTRACT Introduction: In patients with mechanical prosthetic heart valves or atrial fibrillation requiring anticoagulation to prevent thromboembolic events, several factors influence adherence and anticoagulation complications. Objective: To evaluate the factors that interfere with the quality and complications of anticoagulation with vitamin K antagonists. Methods: A retrospective cohort study of 100 patients, in the period from 2011 to 2014, was performed. Anticoagulation conditions in the last year, regarding the presence of complications (embolisms/bleeding) and inadequate treatment were assessed: achievement of less than 8 annual prothrombin times and International Normalized Ratio outside therapeutic target in more than 40% of prothrombin times. Results: There were 31 complications (22 minor bleeding without hospitalization and 9 major complications: 7 bleeding with hospitalization and two emboli); 70 were with International Normalized Ratio outside the target in more than 40% of the tests and 36 with insufficient number of prothrombin times. Socioeconomic factors, anticoagulant type and anticoagulation reason had no relationship with complications or with inadequate treatment. There were more complications in patients with longer duration of anticoagulation (P=0.001). Women had more International Normalized Ratio outside the target range (OR 2.61, CI:1.0-6.5; P=0.04). Patients with lower number of annual prothrombin times had longer times of anticoagulation (P=0.03), less annual consultations (P=0.02) and less dose adjustments (P=0.003). Patients with longer duration of anticoagulation have more complications (P=0.001). Conclusion: There was a high rate of major complications and International Normalized Ratio was outside the goal. Less annual prothrombin times was related to longer duration of anticoagulation, less annual consultations and less dose adjustments. More major complications occurred in patients with longer duration of anticoagulation.

ABSTRACT Rupture of the left ventricular wall after mitral valve replacement is an infrequent but lethal complication. Reporting correction technique of ventricular rupture with bovine pericardium patch secured with glue and without suturing: a 51 years-old female patient, with double rheumatic mitral lesion, severe stenosis and discrete insufficiency, who had a mitral valve replacement. During surgery, the patient presented a ventricular rupture of the posterior wall (atrioventricular disruption), which was successfully repaired using bovine pericardium with sutureless biological glue over the epicardium of the damaged area. Sixty months after surgery the patient has no symptoms.

ABSTRACT OBJECTIVE: The aim of the present study was to investigate the factors associated with chronic post-sternotomy pain in heart surgery patients. METHODS: Between January 2013 and February 2014, we evaluated 453 patients with >6 months post-sternotomy for cardiac surgery at a surgical outpatient clinic. The patients were allocated into a group with chronic post-sternotomy pain (n=178) and a control group without pain (n=275). The groups were compared for potential predictors of chronic post-sternotomy pain. We used Cox proportional hazards regression to determine which independent variables were associated with the development of chronic post-sternotomy pain. RESULTS: In total, 39.29% of the patients had chronic poststernotomy pain. The following factors were significantly associated with chronic post-sternotomy pain: (a) use of the internal thoracic artery in coronary bypass grafting (P =0.009; HR=1.39; 95% CI, 1.08 to 1.80); (b) a history of antidepressant use (P =0.0001; HR=2.40; 95% CI, 1.74 to 3.32); (c) hypothyroidism (P =0.01; HR=1.27; 95% CI, 1.03 to 1.56); (d) surgical wound complication (P =0.01; HR=1.69; 95% CI, 1.08 to 2.63), and (e) patients on disability benefits or scheduled for a consultative medical examination for retirement (P =0.0002; HR=2.05; 95% CI, 1.40 to 3.02). CONCLUSION: The factors associated with chronic poststernotomy pain were: use of the internal thoracic artery; use of antidepressants; hypothyroidism; surgical wound complication, and patients on disability benefits or scheduled for a consultative examination.

ResumoObjetivo:O objetivo do presente trabalho foi avaliar os fatores de risco para acidente vascular encefálico isquêmico em pacientes submetidos à cirurgia cardíaca.Métodos:Entre janeiro de 2010 e dezembro de 2012, foram analisados prospectivamente 519 pacientes consecutivos submetidos à cirurgia cardíaca. A amostra foi dividida em dois grupos: os pacientes com acidente vascular encefálico isquêmico (AVEi) trans e pós-operatório foram alocados no grupo GAVEi (n=22) e os demais pacientes no grupo CControle (n=497). As seguintes variáveis foram comparadas entre os grupos: sexo, idade, estenose carotídea >70%, diabetes em uso de insulina, doença pulmonar obstrutiva crônica, arteriopatia periférica, função renal, angina instável, função do ventrículo esquerdo, infarto agudo do miocárdio recente, hipertensão arterial pulmonar, uso de circulação extracorpórea. Acidente vascular encefálico isquêmico foi definido como presença de sintomas de duração maior que 24 horas associados à alteração em tomografia de crânio. As variáveis foram comparadas, por meio do teste exato de Fisher, Qui quadrado, teste t de Student e regressão logística.Resultados:Verificou-se a ocorrência de acidente vascular encefálico isquêmico em 4,2% dos pacientes e os fatores de risco estatisticamente significativos foram: estenose carotídea de 70% ou mais (P=0,03; OR 5,07; IC 95%: 1,35 a 19,02), diabetes em uso de insulina (P=0,04; OR 2,61; IC 95%: 1,10 a 6,21) e arteriopatia periférica (P=0,03; OR 2,61; IC 95%: 1,08 a 6,28).Conclusão:Foram fatores de risco para acidente vascular encefálico isquêmico: estenose carotídea de 70% ou mais, presença de diabetes em uso de insulina e presença de arteriopatia periférica.

AbstractObjective:The purpose of this study was to evaluate the risk factors for ischemic stroke in patients undergoing cardiac surgery.Methods:From January 2010 to December 2012, 519 consecutive patients undergoing cardiac surgery were analyzed prospectively. The sample was divided into two groups: patients with stroke per and postoperative were allocated in Group GS (n=22) and the other patients in the group CCONTROL (n=497). The following variables were compared between the groups: gender, age, carotid stenosis > 70%, diabetes on insulin, chronic obstructive pulmonary disease, peripheral arteriopathy, unstable angina, kidney function, left ventricular function, acute myocardial infarction, pulmonary arterial hypertension, use of cardiopulmonary bypass. Ischemic stroke was defined as symptoms lasting over 24 hours associated with changes in brain computed tomography scan. The variables were compared using Fisher’s exact test, Chi square, Student’s t-test and logistic regression.Results:Stroke occurred in 4.2% of patients and the risk factors statistically significant were: carotid stenosis of 70% or more (P=0.03; OR 5.07; IC 95%: 1.35 to 19.02), diabetes on insulin (P=0.04; OR 2.61; IC 95%: 1.10 to 6.21) and peripheral arteriopathy (P=0.03; OR 2.61; 95% CI: 1.08 to 6.28).Conclusion:Risk factors for ischemic stroke were carotid stenosis of 70% or more, diabetes on insulin and peripheral arteriopathy.

Paciente do sexo feminino, 47 anos, admitida com queixa de dispneia aos pequenos esforços como único sintoma. Exames clínico, eletrocardiográfico e de laboratório normais. Radiografia de tórax demonstrou massa em base de hemitórax direito, que a tomografia computadorizada de tórax revelou tratar-se de massa cística bem delimitada, medindo cerca de 11,3 x 10,6 x 10,9 cm, sugerindo o diagnóstico de cisto pericárdico. A paciente foi submetida a toracotomia direita para ressecção do cisto. A paciente evoluiu sem intercorrências. O resultado do exame anatomopatológico, ao contrário do esperado, diagnosticou cisto tímico.

A 47-year-old woman was admitted with a history of dyspnea on mild exertion as her only symptom. Clinical exam, laboratory tests, and electrocardiography were normal. Chest X-ray demonstrated right hemithorax base mass, and CT scan revealed a well-defined cystic mass measuring approximately 11.3 x 10.6 x 10.9 cm, suggesting the diagnosis of pericardial cyst. The patient underwent right thoracotomy for resection of the cyst. The patient's progress- was uneventful. The result of histopathological examination, contrary to expectations, revealed thymic cyst.

OBJETIVO: Os objetivos do presente trabalho foram identificar variáveis preditivas de mortalidade hospitalar em endocardite infecciosa e criar fórmula matemática para cálculo do risco de óbito e um escore de risco, comparando os dois métodos com a curva ROC. MÉTODO: Foram estudados, retrospectivamente, 186 casos consecutivos de endocardite infecciosa (EI) confirmados, divididos em dois grupos: alta (137) e óbito hospitalar (49). A partir das razões das chances obtidas em análise multivariada, foram criados: uma fórmula para cálculo do risco de óbito e um escore de risco. RESULTADOS: Fatores preditivos de maior mortalidade (análise multivariada) e o escore de risco com seus respectivos pesos foram: idade > 40 anos (RC = 4.16-95%I.C. [1.63,10.80] - 4 pontos), insuficiência cardíaca classe IV ou choque cardiovascular (RC = 4.93 - 95%I.C. [1.86,13.05] - 5 pontos), sepsis não-controlada (RC =5.97 - 95%I.C. [1.95,18.35] - 6 pontos), distúrbio de condução (RC = 5.07-95%I.C. [1.67,15.35] - 5 pontos), arritmia (RC = 8.17 - 95%I.C. [2.60,25.71] - 8 pontos), valva com grande destruição ou abscesso ou prótese (RC = 4.77-95%I.C. [1.44,15.76] - 5 pontos), e vegetação grande e móvel (RC = 4.36-95%I.C. [1.55,12.90] - 4 pontos). Pacientes com escore entre 0 e 10 tiveram 5,26% de MT e maior que 20: 78,9%. CONCLUSÕES: Quanto maior o escore, maior é a mortalidade, complemente-se, ainda, que a estimativa de mortalidade obtida por cálculo ou pelo escore é semelhante. É possível utilizar software para facilitar a aplicação do escore e calcular risco de mortalidade por endocardite infecciosa.

OBJECTIVE: This study aimed at identifying predictive variables for in-hospital mortality, calculating the probability of death and creating a risk index for death by infective endocarditis by comparing two methods using a Receiver Operating Characteristic (ROC) curve. METHODS: A retrospective study was conducted of 186 consecutive cases of confirmed infective endocarditis divided into two groups: discharged (137) and in-hospital death (49). Based on the odds ratios obtained by multivariate analysis, the probability of death was calculated and a mortality risk index created. RESULTS: Factors predictive of higher mortality (multivariate analysis) and the risk index, with their repective weights were: age > 40 years (OR = 4.16; 95%CI [1.63-10.80] - 4 points), class IV heart failure or cardiovascular shock (OR = 4.93; 95%CI [1.86-13.05] - 5 points), uncontrolled sepsis (OR = 5.97; 95%CI [1.95-18.35] - 6 points), conduction disorder (OR = 5.07; 95%CI [1.67-15.35] - 5 points), arrhythmia (OR = 8.17; 95%CI [2.60-25.71] - 8 points), valve with extensive damage or abscess or prosthesis (OR = 4.77; 95%CI [1.44-15.76] - 5 points) and large and mobile vegetation (OR = 4.36; 95%CI [1.55-12.90] - 4 points). Patients with scores between 0 and 10 had a mortality of 5.26% and scores over 20 of 78.9%. CONCLUSIONS: The higher the score, the higher the mortality rate. The mortality risk index may be used to estimate mortality in Infective Endocarditis.

Desde os primeiros relatos sobre aneurismectomia do ventrículo esquerdo, vários aspectos foram estabelecidos. Existem controvérsias relacionadas à técnica ideal de reconstrução ventricular, seus efeitos na morfolofia, função ventricular, estado sintomático pós-operatório e sobrevida a longo prazo. Este estudo visa levantar a casuística do Serviço, observando as principais indicações e tratamento cirúrgico, o estado sintomático pré e pós-operatório e a sobrevida imediata e tardia dos pacientes. Foram avaliados 12 portadores de aneurisma do ventrículo esquerdo, 9 masculinos, idade média de 60 anos, cujas principais indicações cirúrgicas foram angina (58%) e angina + insuficiência cardíaca (42%). O cateterismo cardíaco demonstrou acinesia/discinesia segmentar em 92% dos pacientes, aneurisma apical ou ântero-apical em 83% e doença coronária obstrutiva em 100%, acometendo 3 ou mais vasos em 75%; a artéria interventricular anterior foi mais comprometida (29%). A fração de ejeção variou de 32% a 66% e o encurtamento percentual de 15% a 36%. Todos foram submetidos a revascularização do miocárdio, 9 sofreram aneurismectomia do ventrículo esquerdo, 7 com sutura linear e 2 com reconstrução geométrica. O tempo médio de circulação extracorpórea e clampeamento aórtico foi 96 e 50 minutos para sutura linear e 180 e 86 para reconstrução geométrica. As principais intercorrências pós-operatórias foram síndrome de baixo débito cardíaco e fibrilação atrial (16%). A mortalidade hospitalar foi de 16%. Os pacientes encontram-se com seguimento médio de 15 meses, sobrevida geral de 75%; estão livres de angina 89%, aqueles operados por ICC estão em classe II. Esses fatores melhorando a qualidade de vida justificam a aneurismectomia.

Since the first reports about left ventricular aneurysmectomy, many features have been established, but there are controversies concerning the ideal technique of left ventricular reconstruction and their effects on morphology, ventricular function, symptomatic state and longevity. This study was designed to evaluate the cases of left ventricular aneurysm relating the main surgical indications and treatment and the patients' symptomatic state before and after operation. The study involves 12 patients with left ventricular aneurysm, nine males, mean age 60 years, whose main indications for surgery were angina (58%) and angina plus congestive heart failure (42%). Ventricular cineangiograms revealed an akinetic/dyskinetic segment in 92% of patients, apical or anteroapical aneurysm in 83% and coronary artery disease in 100%, affecting 3 or more vessels in 75%, the left anterior descending artery was most affected (29%). The ejection fraction ranged from 32% to 66%. All patients underwent coronary artery bypass grafting, nine had left ventricular aneurysmectomy, seven through linear closure and 2 through geometric reconstruction. The cardiopulmonary bypass and aortic cross-clamp mean time was 96 and 50 minutes for linear closure and 180 and 86 for geometric reconstruction. The main complications after surgery were low cardiac output and atrial fibrillation (16%). Hospital mortality rate was 16%. Patients have a mean follow up of 15 months, survival rate is 75%, those surgically treated for CHF are in class II and 89% are angina-free. These improvements in quality of life provide justification for aneurysmectomy.